share_log

Earnings Call Summary | Paragon 28(FNA.US) Q1 2024 Earnings Conference

Earnings Call Summary | Paragon 28(FNA.US) Q1 2024 Earnings Conference

财报电话会议摘要 | Paragon 28 (FNA.US) 2024 年第一季度财报会议
moomoo AI ·  05/12 04:34  · 电话会议

The following is a summary of the Paragon 28, Inc. (FNA) Q1 2024 Earnings Call Transcript:

以下是百丽宫28公司(FNA)2024年第一季度财报电话会议记录的摘要:

Financial Performance:

财务业绩:

  • Paragon 28 globally achieved a Q1 2024 revenue of $61.1 million, an increase of 17.4%.

  • US business saw net revenue of $51.1 million in Q1, a 13.5% increase, with contributions from the increase in producing sales rep roster.

  • International net revenue for Q1 was $10 million, indicating a 42.2% reported growth.

  • Gross profit margin for Q1 was 80%, a decrease from 82.9% in Q1 2023 due to higher supplier prices and product/geographic mix shift.

  • Q1 2024 saw an increase in Selling, general, and administrative expenses, reaching $54.2 million, a rise of 23.7% from Q1 2023.

  • The company reported an increased adjusted EBITDA loss of $5.5 million for Q1 2024.

  • Operating cash flow was negative $11 million in Q1 2024 compared to negative $5 million in Q1 2023.

  • Paragon ended Q1 2024 with a total liquidity of $58 million in cash and $50 million available through a credit facility.

  • 2024 net revenue guidance is reaffirmed at $249 million to $259 million.

  • 百丽宫28全球在2024年第一季度实现了6,110万美元的收入,增长了17.4%。

  • 美国业务在第一季度净收入为5,110万美元,增长13.5%,这要归因于生产销售代表名单的增加。

  • 第一季度的国际净收入为1000万美元,表明报告的增长率为42.2%。

  • 由于供应商价格上涨和产品/地域结构的变化,第一季度的毛利率为80%,低于2023年第一季度的82.9%。

  • 2024年第一季度的销售、一般和管理费用有所增加,达到5,420万美元,较2023年第一季度增长23.7%。

  • 该公司报告称,2024年第一季度调整后的息税折旧摊销前利润亏损增加了550万美元。

  • 2024年第一季度的运营现金流为负1,100万美元,而2023年第一季度的运营现金流为负500万美元。

  • 截至2024年第一季度,Paragon的总流动性为5800万澳元现金,5000万美元可通过信贷额度获得。

  • 2024年的净收入预期为2.49亿美元至2.59亿美元。

Business Progress:

业务进展:

  • Record six new product launches and a limited market release in Q1 targeted high-growth Foot and Ankle segments.

  • Investment in product development continued, adding 6% to the US producing sales rep roster.

  • Significant international market expansions were made, particularly in the United Kingdom and Australia.

  • Over 25 active projects in pipeline, with several aligned with Smart28.

  • Reiteration of commitment to operating leverage and cost management while also investing in commercial and educational opportunities.

  • Expectation of OpEx reduction as a percentage of revenue in future quarters as revenue increases and previous operational expense investments are leveraged.

  • Successful launching of new products in the bunion market, like MIS, bunion portfolio, and FJ 2000, which are surpassing expectations.

  • Continuation of investment in innovation and technology with a consistent percentage of revenue on R&D planned for the future.

  • Geographic expansion plans underway including an increase in the US salesforce and broader international expansion.

  • Full product launch planned in the coming months for the Lapidus clamp, currently in limited release.

  • 第一季度创纪录的六款新产品发布和限量市场发布的目标是高增长的足部和脚踝细分市场。

  • 对产品开发的投资仍在继续,美国生产销售代表名单增加了6%。

  • 国际市场进行了重大扩张,特别是在英国和澳大利亚。

  • 超过25个活跃的项目正在筹备中,其中一些项目与Smart28保持一致。

  • 重申对运营杠杆和成本管理的承诺,同时也投资于商业和教育机会。

  • 随着收入的增加和先前的运营费用投资的杠杆作用,预计未来几个季度运营支出占收入的百分比将减少。

  • 成功在拇囊炎市场上推出了超出预期的新产品,例如MIS、拇囊炎产品组合和FJ 2000。

  • 继续投资于创新和技术,并计划在未来保持稳定的研发收入百分比。

  • 地域扩张计划正在进行中,包括增加美国销售队伍和更广泛的国际扩张。

  • Lapidus夹具计划在未来几个月内全面上市,目前为限量发行。

More details: Paragon 28 IR

更多详情: Paragon 28 红外线

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:本文由 AI 生成。无法完全保证内容的准确性。欲了解更多详情,请访问投资者关系网站。本文仅供投资者参考,不构成任何投资建议。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发